Prostate cancer-specific anxiety in Dutch patients on active surveillance: validation of the memorial anxiety scale for prostate cancer
- PMID: 19669670
- PMCID: PMC2744806
- DOI: 10.1007/s11136-009-9516-9
Prostate cancer-specific anxiety in Dutch patients on active surveillance: validation of the memorial anxiety scale for prostate cancer
Abstract
Purpose: Men with prostate cancer (PC) may show specific disease-related anxiety. We evaluated the psychometric properties of the Dutch adaptation of the Memorial Anxiety Scale for Prostate Cancer (MAX-PC).
Methods: The MAX-PC was translated using standardized forward-backward procedures. Patients (N = 150) on active surveillance, a strategy of initially withholding active therapy, for recently diagnosed early PC were mailed a questionnaire. Internal consistency was estimated using Cronbach's alpha. The scale structure was analyzed using confirmatory factor analysis (CFA). Construct validity was evaluated by Pearson's correlations between MAX-PC scores and scores on decisional conflict (DCS), generic anxiety (STAI), depression (CES-D), and general mental health (SF-12 MCS).
Results: Data from 129 respondents were used (response rate 86%). Cronbach's alpha for the total score and the three subscales were 0.77, 0.91, 0.64, and 0.85, respectively. CFA largely confirmed the three-factor structure as used in the original publication (model fit: chi(2) 149, P = 0.051). The patterns of directions and sizes of the correlations (r = 0.36-0.66) between MAX-PC scale scores and the other variables were in accordance with a priori hypotheses, except for the prostate-specific antigen anxiety subscale. The relatively poor performance of this scale in the original version was replicated.
Conclusions: The structure and validity of the MAX-PC to quantify PC-specific anxiety were largely confirmed in Dutch patients.
References
-
- {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1093/annonc/mdi098', 'is_inner': False, 'url': 'https://doi.org/10.1093/annonc/mdi098'}, {'type': 'PubMed', 'value': '15718248', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/15718248/'}]}
- Boyle, P., & Ferlay, J. (2005). Cancer incidence and mortality in Europe, 2004. Annals of Oncology,16(3), 481–488. - PubMed
-
- {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.3322/CA.2007.0010', 'is_inner': False, 'url': 'https://doi.org/10.3322/ca.2007.0010'}, {'type': 'PubMed', 'value': '18287387', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/18287387/'}]}
- Jemal, A., Siegel, R., Ward, E., Hao, Y., Xu, J., Murray, T., et al. (2008). Cancer statistics, 2008. CA: A Cancer Journal for Clinicians,58(2), 71–96. - PubMed
-
- {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1002/cncr.11386', 'is_inner': False, 'url': 'https://doi.org/10.1002/cncr.11386'}, {'type': 'PubMed', 'value': '12767107', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/12767107/'}]}
- Roth, A. J., Rosenfeld, B., Kornblith, A. B., Gibson, C., Scher, H. I., Curley-Smart, T., et al. (2003). The memorial anxiety scale for prostate cancer: Validation of a new scale to measure anxiety in men with prostate cancer. Cancer,97(11), 2910–2918. - PubMed
-
- {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1176/appi.psy.47.4.340', 'is_inner': False, 'url': 'https://doi.org/10.1176/appi.psy.47.4.340'}, {'type': 'PubMed', 'value': '16844894', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/16844894/'}]}
- Roth, A., Nelson, C. J., Rosenfeld, B., Warshowski, A., O’Shea, N., Scher, H., et al. (2006). Assessing anxiety in men with prostate cancer: Further data on the reliability and validity of the memorial anxiety scale for prostate cancer (MAX-PC). Psychosomatics,47(4), 340–347. - PubMed
-
- {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1002/pon.1107', 'is_inner': False, 'url': 'https://doi.org/10.1002/pon.1107'}, {'type': 'PubMed', 'value': '17080494', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/17080494/'}]}
- Dale, W., Hemmerich, J., & Meltzer, D. (2007). Extending the validity of the memorial anxiety scale for prostate cancer (MAX-PC) at the time of prostate biopsy in a racially-mixed population. Psychooncology,16(5), 493–498. - PubMed